You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

Alerts

Article menu
Download PDFPDF
ABSTRACT: Oral Poster Presentations: Cervical Cancer Tuesday, October 17, 2006
0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address